to evaluate the role of shirobasti in stroke syndrome in patients with speech difficulty

A CLINICAL STUDY TO EVALUATE THE EFFECT OF SHIROBASTI IN PAKSHAGHATA ASSOCIATED WITH VAK VIKRITI W.S.R TO SPEECH DISABILITIES IN STROKE SYNDROME - nil

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096516

Enrollment

Registered

2025-10-28

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G819- Hemiplegia, unspecified

Interventions

Intervention1: prasarini taila: shirobasti in stroke syndrome Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: stabilized Patients of known case of Pakshaghata stroke Within the chronicity of 3 years Patients aged between 16 70 years Patients fit for Shirobasti

Exclusion criteria

Exclusion criteria: History of cognitive or behavioural complaints• History of psychiatric illness, dementia, hearing impairment, drug abuse and severe alcoholismand other systemic illness• Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of shirobasti in treating vak vikriti in pakshagatha w s r aphasia and dysarthriaTimepoint: 7 days	—

Secondary

Measure	Time frame
to improve Vak sanga ,Mooka Gadgada vak Minmina vak Deena vak Jihma vak Samukshipta vak Kala vakTimepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Manjunatha N

SDM COLLEGE OF AYURVEDA AND HOSPITAL UDUPI

drrajalaxmisdm@gmail.com9448951673

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026